Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 29, 2005
Human Molecular Genetics 2005 14(15):2209-2219; doi:10.1093/hmg/ddi225
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
14/15/2209    most recent
ddi225v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mehenni, H.
Right arrow Articles by Antonarakis, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehenni, H.
Right arrow Articles by Antonarakis, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes

Hamid Mehenni1,2,*, Nathalie Lin-Marq2, Karine Buchet-Poyau2,{dagger}, Alexandre Reymond2,{ddagger}, Martine A. Collart3, Didier Picard1 and Stylianos E. Antonarakis2

1Département de Biologie Cellulaire, Université de Genève, 1211 Genève 4, Switzerland, 2Département de Médecine Génétique et Développement and 3Département de Microbiologie et Médecine Moléculaire, Université de Genève, Centre Médical Universitaire, 1211 Genève 4, Switzerland

* To whom correspondence should be addressed at: Département de Biologie Cellulaire, Université de Genève, Sciences 3, 30 quai Ernest-Ansermet, 1211 Genève 4, Switzerland. Tel: +41 223796811; Fax: +41 223281157; Email: mehenni{at}cellbio.unige.ch

Received June 8, 2005; Accepted June 17, 2005

Germline mutations of the LKB1 (STK11) tumor suppressor gene lead to Peutz-Jeghers syndrome (PJS) and predisposition to cancer. LKB1 encodes a serine/threonine kinase generally inactivated in PJS patients. We identified the dual phosphatase and tumor suppressor protein PTEN as an LKB1-interacting protein. Several LKB1 point mutations associated with PJS disrupt the interaction with PTEN suggesting that the loss of this interaction might contribute to PJS. Although PTEN and LKB1 are predominantly cytoplasmic and nuclear, respectively, their interaction leads to a cytoplasmic relocalization of LKB1. In addition, we show that PTEN is a substrate of the kinase LKB1 in vitro. As PTEN is a dual phosphatase mutated in autosomal inherited disorders with phenotypes similar to those of PJS (Bannayan–Riley–Ruvalcaba syndrome and Cowden disease), our study suggests a functional link between the proteins involved in different hamartomatous polyposis syndromes and emphasizes the central role played by LKB1 as a tumor suppressor in the small intestine.


{dagger} Present address. Laboratoire Génétique Moléculaire, Signalisation et Cancer, CNRS UMR 5201, Domaine Rockefeller-Université Lyon 1, 8 Avenue Rockefeller, 69008 Lyon, France.

{ddagger} Present address. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.

These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
A. Londesborough, K. Vaahtomeri, M. Tiainen, P. Katajisto, N. Ekman, T. Vallenius, and T. P. Makela
LKB1 in endothelial cells is required for angiogenesis and TGF{beta}-mediated vascular smooth muscle cell recruitment
Development, July 1, 2008; 135(13): 2331 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Song, Z. Xie, Y. Wu, J. Xu, Y. Dong, and M.-H. Zou
Protein Kinase C{zeta}-dependent LKB1 Serine 428 Phosphorylation Increases LKB1 Nucleus Export and Apoptosis in Endothelial Cells
J. Biol. Chem., May 2, 2008; 283(18): 12446 - 12455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. B. Pearson, A. McCarthy, C. M.P. Collins, A. Ashworth, and A. R. Clarke
Lkb1 Deficiency Causes Prostate Neoplasia in the Mouse
Cancer Res., April 1, 2008; 68(7): 2223 - 2232.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J.-L. Liu, Z. Mao, T. A. LaFortune, M. M. Alonso, G. E. Gallick, J. Fueyo, and W.K. A. Yung
Cell Cycle Dependent Nuclear Export of Phosphatase and Tensin Homologue Tumor Suppressor Is Regulated by the Phosphoinositide-3-Kinase Signaling Cascade
Cancer Res., November 15, 2007; 67(22): 11054 - 11063.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Song, Y. Wu, J. Xu, Z. Xie, Y. Dong, M. Zhang, and M.-H. Zou
Reactive Nitrogen Species Induced by Hyperglycemia Suppresses Akt Signaling and Triggers Apoptosis by Upregulating Phosphatase PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) in an LKB1-Dependent Manner
Circulation, October 2, 2007; 116(14): 1585 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P.-Y. Zeng and S. L. Berger
LKB1 Is Recruited to the p21/WAF1 Promoter by p53 to Mediate Transcriptional Activation.
Cancer Res., November 15, 2006; 66(22): 10701 - 10708.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Z.-G. Zhuang, G.-H. Di, Z.-Z. Shen, J. Ding, and Z.-M. Shao
Enhanced Expression of LKB1 in Breast Cancer Cells Attenuates Angiogenesis, Invasion, and Metastatic Potential
Mol. Cancer Res., November 1, 2006; 4(11): 843 - 849.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Gil, A. Andres-Pons, E. Fernandez, M. Valiente, J. Torres, J. Cervera, and R. Pulido
Nuclear Localization of PTEN by a Ran-dependent Mechanism Enhances Apoptosis: Involvement of an N-Terminal Nuclear Localization Domain and Multiple Nuclear Exclusion Motifs
Mol. Biol. Cell, September 1, 2006; 17(9): 4002 - 4013.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Mehenni, N Resta, J-G Park, M Miyaki, G Guanti, and M C Costanza
Cancer risks in LKB1 germline mutation carriers
Gut, July 1, 2006; 55(7): 984 - 990.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.